Hjem › Neuroblastom › Oregon › Portland
Neuroblastom kliniske forsøg i Portland, OR
6 studier for Neuroblastom søger deltagere på steder i og omkring Portland (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RekruttererFase 3
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RekruttererFase 1/2
- Oregon Health and Science University ( Site 1004), Portland
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
RekruttererFase 2
- Randall Children's Hospital, Portland
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
RekruttererFase 2
- Randall Children's Hospital, Portland
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RekruttererFase 3
- Legacy Emanuel Children's Hospital, Portland
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
RekruttererFase 2
- Randall Children's Hospital, Portland
Neuroblastom forsøg i andre byer
- Boston, MA13 studier
- Washington, DC11 studier
- New York City, NY10 studier
- Dallas, TX9 studier
- Memphis, TN9 studier
- Philadelphia, PA9 studier
- St. Louis, MO9 studier
- Aurora, CO8 studier
- Hartford, CT8 studier
- Minneapolis, MN8 studier
- Birmingham, AL8 studier
- Atlanta, GA7 studier
Andre studier i Portland
- Ikke-småcellet lungecancer46 studier
- Kræft (alle typer)34 studier
- Prostatakræft33 studier
- Brystkræft33 studier
- Metastatisk cancer29 studier
- Colorektal kræft28 studier
- Ægstockræft27 studier
- Lungecancer26 studier
- Akut myeloid leukæmi25 studier
- Livmoderslimhindekræft24 studier
- Pladecellekræft i hoved og hals19 studier
- Bugspytkirtelkræft19 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.